Melatonin initiates physiologic and therapeutic responses in various tissues through binding to poorly defined MT receptors regulated by G-proteins and purine nucleotides. Melatonin's interaction with other G-protein regulated receptors, including those of serotonin, is unclear. This study explores the potential for the interaction of melatonin with nucleotide and receptor ligand structures.
Melatonin promotes circadian rhythms and physiological effects on systems outside of the CNS through widely expressed receptors (Johnston and Skene 2015; Jockers et al. 2016) . Melatonin analogues have considerable therapeutic potential and already find use as adjuvant therapy, for disorders of the eye and gut, hypertension, diabetes, insomnia, in cancer treatment and surgical procedures (Sanchez-Barcelo et al. 2010; Liu et al. 2016) . As a derivative of serotonin, melatonin might be expected to initiate some physiologic responses through the regulation of 5-HT receptors. In this respect, melatonin induced hypothermia in rats is abolished by compounds targeting serotonin receptors (Lin and Chuang 2002) . Serotonin is a potent inhibitor of melatonin binding to human platelet membranes (Vacas et al. 1992) . Inhibition of the delayed rectifier K + current in rat hippocampal neurons is attributable to the indole moiety of serotonin and melatonin (Hou et al. 2004 ). In the gastrointestinal tract, melatonin inhibits the action of serotonin on peristalsis (Bubenik 2008) . Agomelatine, an antidepressant naphthalenic analogue of melatonin, has affinity for MT and 5-HT 2c receptors (Ettaoussi et al. 2013) . Data relating to the effects of melatonin on 5-HT receptors are, however, contradictory. Lucchelli and co-workers (1997) have reported that melatonin does not interact with 5-HT receptors (5-HT 1 -5-HT 4 ) in contracting guinea-pig proximal colon. Kamal and co-workers (2015) , following characterization of functional MT 2 and 5-HT 2c heteromers in HEK293 cells, have maintained that there is no interaction between the endogenous agonists.
Identical MT ligand-binding characteristics and the limited modelling of melatonin receptors hinder the development of specific therapeutic agents (Chan and Wong 2013) . Melatonin MT 1 and MT 2 receptors couple to the Gi/o family of G-proteins, initiating signal transduction by inhibiting adenyl cyclase, K + channel opening via βλ subunits and Ca 2+ channel closure (Tosini et al. 2014) . Gi/o cell signal transduction processes are common to muscarinic (M 2 , M 4 ), α-adrenoceptor (α 2 ), serotonin (5-HT 1 ), histamine (H 4 ), dopamine (D 2 ) and opioid receptors (Southan et al. 2016) . MT 1 receptors also couple to the Gq/G 11 alpha protein and activate phospholipase C in common with muscarinic (M 1 , M 3 , M 5 ), adrenoceptor (α 1 ), histamine (H 1 ) and serotonin (5-HT 2 ) receptors (Southan et al. 2016) . Gα q links GPCRs to a Rho family GTPase (RhoA) catalysed by p63RhoGEF, a guanine nucleotide exchange factor (Lyon et al. 2014) . Nitric oxide and guanylyl cyclase are also involved in the anti-adrenergic, cardioprotective and local antinociceptive effects of melatonin (Genade et al. 2008; Hernandez-Pacheco et al. 2008; Yu et al. 2017) . Freeradical scavenging and protection of the electron transport chain contribute further to the properties of melatonin (Hardeland 2017) .
In this study, factors contributing to the pleiotropic properties of the melatonin molecule are explored in respect of signal transduction mechanisms regulating Gα protein and ion channel receptors. The binding of GTP to G-proteins, initiating GPCR signalling, is used to assay receptor ligand potency (Strange 2010) . Previous work has demonstrated the utility of molecular modelling software and established structure-activity data for identifying similarity within receptor ligands in comparison to guanine and adenine nucleotide templates. Ligands of GPCRs and ion channels provide unique fits to nucleotide templates (Williams 2018) . The study uses a com- putational program to study molecular similarity within the structures of melatonin, purine nucleotides, GPCR, and ion channel ligands. The research aims are to contribute to a better understanding of melatonin's interaction with so many classes of cell membrane receptor.
Methods
Compounds representative of receptor ligands regulating Gα i and Gα q proteins are listed in Table 1 and Table 2 . Molecular formulae of the investigated compounds are listed in IUPHAR (Southan et al. 2016) and Pubchem (http://pubchem.ncbi.nlm.nih. gov) databases. The Nemesis software program (Oxford Molecular version 2.1) is used to build molecular structures, from contents of the program fragment file, and obtain minimum energy conformers by conformational analysis. The ligand structures are minimum energy conformers in an uncharged form. The low energy conformers of ATP and GTP nucleotides are used in a previous setting (Williams 2011) . Torsion angles describing the conformer of the melatonin molecule (see Figure 2 ) are: O6C6N1C10 176°, C6N1C10C9-105°, N1C10C9C8 64°, C10C9C8C7 81°. The computational program fits paired molecular structures on a 3 point basis. Fitting points comprise of atoms of similar type and partial charge within ligand and nucleotide structures and are identified with respect to the nucleotide. The fitting sequence of each compound to a nucleotide template is given in Table 1 and Table 2 (reading from left to right). Ligand fitting points are identified in the Figures by colourcoded atoms: carbon-green, nitrogen-blue, oxygenred. Bond order within molecular structures is not shown and the nucleotide structures are cropped, to improve on presentation. The Nemesis program computes goodness-of-fit values in respect of inter-atomic distance at each fitting point and root mean square (RMS) value.
Results
The fit of the isoprenaline structure to the adenine nucleotide template (Figure 1[1] ) demonstrates the potential of this β-adrenoceptor agonist to promoting cyclisation of ATP by adenyl cyclase; a Gα s regulated process requiring condensation of the nucleotide 3-hydroxyl and α-phosphate groups. Although melatonin [2] has an equivalent N6-O2 distance to isoprenaline (6.8Å), it cannot provide the same fit to the ATP template. The C5C3'O3 fit [2] places the methoxy group of melatonin in an inhibitory position in regard to the cyclisation of ATP. The other template fits in Figure 1 also relate to structures that oppose nucleotide cyclisation via regulation of Gα i . Agonists of dopamine [3, 4] , morphine [7, 9] and serotonin [13, 15, 17] receptors fit with inhibitory groups in proximity to the nucleotide ribose ring hydroxyls. Sumanirole subtends an aminomethyl group from C2'; pramipexole, morphine, SNC80 and LY344864 target the 03 hydroxyl. In contrast, antagonists of dopamine and α 2 -adrenoceptor receptors, L750667 The many different fits of the melatonin conformer to the guanine nucleotide template are given in Figure 2 . As exemplified by the M1 agonist structure MCN-A343 [1] some fits of melatonin to the nucleotide template are peripheral [2-6], whereas others [7] [8] [9] [11] [12] [13] [14] [15] show the cyclic rings of melatonin superimposed on those of the nucleotide structure. Fits of the minimum energy melatonin conformer are compared to those given by GPCR ligands (AchM, α 2 -adrenergic, 5-HT 2 ), ligand-gated (GABA A, glycine, glutamate, 5-HT 3 ) and voltage-gated (K + , Ca 2+ ) ion channels. The fits of agonist structures [1, 18, 29] tend to be more peripheral than their corresponding antagonists [16, 19, 30] . The fitting points provided by the acetyl and methoxy groups of melatonin [2] describe a pharmacophore that may relate to the MT 1 receptor and an inhibitory effect on GTP cyclisation. Melatonin and GTP O6-O2 distances are respectively 7.8Å and 7.9Å. Templates 3 and 4, with fitting points on the guanine ring carbonyl group, relate to NMDA [26, 27] 
Discussion
The data obtained in this investigation demonstrate that melatonin replicates pharmacophoric patterns established for class specific receptor ligands fitting to nucleotide templates. Molecular similarity is evident in GPCR and ion channel ligands relative to the structures of purine nucleotides that control signal transduction events (Williams 2018) . The 3-acylaminoethyl chain and 5-methoxy group are crucial components in the binding of melatonin to MT 1 and MT 2 receptors, as is the relative distance between the amide group and methoxy group (Chan and Wong 2013) . The nucleotide template fits of the melatonin conformer via acyl and methoxy groups, given in Figures 1 [2] and 2[2], may relate to MT 1 and MT 2 receptor pharmacophores.
In regard to adenine nucleotide, the relative molecular similarity identified within melatonin, dopamine, serotonin, and opioid ligand structures has functional significance, in respect of inhibitory effects on cAMP formation. The anti-nociception pathway elicited by melatonin in rodents is complex with involvement of opioid, serotonin, acetylcholine, dopamine, α-adrenoceptor and arginine-NO receptors (Mantovani et al. 2006; Shin et al. 2011) . Melatonin reduces hypokinesis and stereotypies induced by D2 ligands and has a synergistic effect with apomorphine in the mouse tail suspension test (Sumaya et al. 2004; Binfare et al. 2010) . Melatonin induced hypothermia in rats is significantly reduced by treatment with either a 5-HT 2A receptor agonist or 5-HT 1A receptor antagonist (Lin and Chuang 2002) . In patients, sulpiride and melatonin decrease tinnitus perception by decreasing dopamine activity (Lopez-Gonzalez et al. 2007) . Clinical and experimental studies demonstrate that melatonin interacts with the α 2 -agonist clonidine. Clonidine administration decreases urine and plasma melatonin levels in depressed patients and sleeping volunteers (Lewy et al. 1986; Paparrigopoulos et al. 2001) . Melatonin impairs contractile responses to clonidine in rat aorta preparations (Weekley 1991) . Evidence for melatonin interaction with the cholinergic system arises from studies on seizures, epilepsy and cognitive deficits. Melatonin improves cognitive deficits in mice with scopolamine-induced amnesia and has found use in the clinical treatment of selected patients with epilepsy (Banach et al. 2011; Chen et al. 2018) .
The molecular similarity identified within melatonin and adenine nucleotide is also applicable to the structure and function of guanine nucleotide. Interaction of melatonin with the NOS-cGMP pathway results in a vasorelaxing, cGMP dependent, action on rat aorta contracted by 5-HT and inhibition of NOS activity in mouse colonic neurons (Satake et al. 1991; Storr et al. 2002) . The participation of MT receptors in the inhibitory effects of melatonin on NO and cGMP production by bradykinin in rat endothelial cells is, however, contentious (Tamura et al. 2006) . Melatonin is reported to enhance GABA and muscimol affinity for the GABA A receptor, via a melatonin receptor independent mechanism analogous to benzodiazepine action (Coloma and Niles 1988; Dhanaraj et al. 2004; Cheng et al. 2012) . The relevance of melatonin to GABA A and glutamate receptor activity is evident in its replication of GABA, pentylenetetrazole, diazepam and glutamate fits to the nucleotide template. Melatonin reduces experimental convulsions initiated by pentylenetetrazole, kainate and compounds acting on NMDA excitatory glutamatergic receptors (Lapin et al. 1998; Banach et al. 2011) . Potentiation of the glycine current by melatonin in rat ganglionic cells is attributed to the MT 2 receptor (Zhao et al. 2010) .
The molecular similarity within guanine nucleotide and melatonin structures extends to the ligands and functional responses of 5-HT 3, K + and Ca 2+ channels. Studies on delayed gastric emptying in the rat indicate that exogenous melatonin inhibits 5-HT 3 receptors on vagal afferent fibres (Kasimay et al. 2005) . Melatonin blocks several voltage-gated K + channels and interacts with compounds that open or block BK Ca channels (Geary et al. 1998; Varga et al. 2001; Hou et al. 2004) . Contractile responses to melatonin observed in rat tail and cerebral arteries are dependent on the antagonism of BK Ca channels (Geary et al. 1998; Regrigny et al. 1999) . The vasodilation of rat mesenteric artery by melatonin is attributed to direct and indirect (via MT receptors) activation of BK Ca channels (Zhao et al. 2017) . Ca 2+ entry through voltage-gated calcium channels (Cav 2.2 ) can be inhibited by physical interaction of the channel with the MT 1 receptor (Benleulmi-Chaachoua et al. 2016) .
There is substantial evidence within the research literature that MT receptors are not responsible for all physiological effects of melatonin, including studies relating to interaction of the compound with 5-HT ligands and receptors. The data given in this study reveal a molecule multi-functional in respect of interaction with receptor ligand structures: the indole ring of melatonin relates to opiate, α-adrenergic, 5-HT and ion channel ligand structures, whereas the acyl group is relevant to GABA A , glutamate and glycine function. These receptor-based properties of the indolamine structure may provide a general dampening effect on neurotransmitter activity, an especially useful property for initiating sleep and reducing sleep disturbance. The functional relevance attributable to the molecular similarity may derive from the promotion of ligandinduced conformational changes in the nucleotide structures that switch cell signal transduction events, and extend further to nucleotide-binding domains on protein kinases and several classes of ion channel.
